Regrow Biosciences gets USFDA Nod for Phase II trials of ‘OSSGROW’ for Osteonecrosis in the US
OSSGROW is India's first FDA (DCGI) approved product that has treated over 1000 patients across 200 hospitals in the country ...
Tag: Regrow Biosciences
Beyond Ranthambore: Madhya Pradesh’s Quiet Wildlife Tourism Boom
By Deepika Negi, Founder and CEO, BizareXpedition The forest hadn't decided about the light yet when our jeep crossed into...
Read more
